Managing dyslipidemia in diabetic patients: A study from primary care, Oman
1 Family medicine specialist, MOH, Oman.
2 Family medicine specialist, MOH, Oman.
3 Consultant family medicine, Diwan polyclinic, MOH Oman.
4 Professor and HOD Family Medicine Department, College of Medicine, National University, Oman.
Research Article
International Journal of Scholarly Research in Multidisciplinary Studies, 2026, 06(01), 001-008.
Article DOI: 10.56781/ijsrms.2026.6.1.0021
Publication history:
Received on 10 November 2025; revised on 23 January 2026; accepted on 26 January 2026
Abstract:
Background and Objectives: Patients with type 2 diabetes mellitus (T2DM), dyslipidemia is a key risk factor for macrovascular complications .This study aims to evaluate the percentage reduction in LDL-cholesterol levels using 10 mg atorvastatin in diabetic Omani patients for primary prevention. Additionally, it explores various socio-demographic and clinical factors that may influence dyslipidemia management in this population.
Methodology: A quantitative retrospective cohort study was conducted across eight primary healthcare centers in Muscat Governorate from December 2016 to April 2019. The study included all Omani diabetic patients with dyslipidemia, aged over 30 years. Patient data were extracted from electronic medical records and the diabetic registry, including demographics (age, sex, BMI, smoking status, alcohol consumption, dietary habits, education level), disease history (year of diabetes and dyslipidemia diagnosis, diabetes medication, complications), and treatment details (date of atorvastatin initiation, baseline LDL level, and first post-treatment LDL measurement). Statistical analyses were conducted using SPSS version 20.0.
Results: The study included 108 patients (50 women [46.3%] and 58 men [53.7%]). A 35% reduction in LDL levels was observed following treatment with 10 mg atorvastatin over a median period of eight months (p-value = 0.0001).
Physical exercise showed a significant effect on LDL reduction after adjusting for covariates, F(1, 77) = 5.796, p = 0.018, partial η² = 0.070. The adjusted marginal mean LDL level in the exercise group (2.859 mmol/L) was lower than in the non-exercise group (3.475 mmol/L), with a statistically significant difference of 0.616 mmol/L (95% CI, 0.106 to 1.125 mmol/L).
Conclusion: Dyslipidemia is prevalent among diabetic patients. Early detection at the time of diabetes diagnosis is crucial for reducing the risk of atherosclerotic cardiovascular disease (ASCVD). Future prospective studies are needed to mitigate bias and provide more specific insights for Omani patients.
Keywords:
Diabetic dyslipidemia; ASCVD risk calculators; Dyslipidemia; Atorvastatin
Full text article in PDF:
Copyright information:
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0